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ABSTRACT
A previously asymptomatic 44-year-old male crewmember on a cruise ship experienced several brief epi-
sodes of acute chest pain within a short time frame. He was ultimately diagnosed with myocardial infarc-
tion; 5 h earlier he had been discharged from the ship’s medical centre after almost 8 h of monitoring to 
rule-out infarction. Subsequent angiography ashore revealed a 99% occlusion of the right coronary artery. 
This case highlights the dangers of over-reliance on shipboard cardiac enzyme testing to clear a patient 
with chest pain.
(Int Marit Health 2015; 66, 1: 22–24)
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INTRODUCTION
Acute chest pain is a medical challenge, especially at 
sea. What is the cause, can it be treated aboard, and if 
not, what can be done until safe evacuation to definitive 
care is possible? A 44-year-old male seafarer with a 6-h 
history of episodic chest pain is presented; investigation 
and monitoring in the ship’s medical centre disclosed no 
initial cause for concern.
CASE REPORT
Just before noon, directly after a cigarette and an espres-
so coffee prior to starting his watch duty, a previously asymp-
tomatic 44-year-old male crewmember, with no known risk 
factors for cardiac disease other than moderate cigarette 
smoking, experienced a first ever episode of acute chest 
pain. 
The pain was a pressure in the chest, with no radiation 
and no associated symptoms. After 2 min the pain resolved 
spontaneously and completely, only to return 2 h later, 
with the same characteristics and for a similar duration. 
In-between these episodes he was asymptomatic and able 
to perform his normal duties.
Approximately 6 h after the first symptom, the pain 
recurred for a third time. This episode was also asso-
ciated with caffeine and a cigarette. On this occasion 
the pain was slightly more forceful, rated by him as 
2 out of 10 on a verbal pain scale (where 0 represents 
no pain at all) and at this point he decided to seek 
medical attention.
The initial examination was unremarkable. Blood pres-
sure was normal and similar in each arm; the electrocar-
diogram (ECG) was non-diagnostic (Fig. 1) and the initial 
cardiac enzymes were within normal limits.
A working diagnosis of atypical chest pain, possibly due 
to oesophageal spasm, was made. Antacids were prescribed 
along with benzodiazepines as it was felt that patient anxiety 
was not assisting resolution. Neither nitroglycerin nor opi-
ates were administered and the pain settled spontaneously. 
The patient was admitted to “rule out myocardial infarction 
(MI)” by means of serial cardiac enzymes and ECGs.
During the admission the patient’s pain level fluctuated 
between 0 and 1 out of 10, but mostly he was pain free. 
Cardiac enzymes were repeated after approximately 6 h 
of monitoring (corresponding to approximately 13 h from 
his very first symptom and 7 h from the time of maximal 
pain) and remained within normal limits. No changes were 
detected on serial ECG traces.
Just before 3 a.m., after almost 8 h of monitoring, he 
was comfortable, pain-free and allowed back to his cabin. 
He was asked to return at 8 a.m. in the morning for review.
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When the patient returned at 8 a.m., he was clutching 
his chest and sweating profusely, the pain having recurred 
with great severity just a few minutes earlier.
The ECG now showed acute inferior wall MI with ST seg-
ment elevation in the inferior leads II and aVF (Fig. 1) and 
reciprocal ST segment depression in antero-lateral leads I, 
aVL and V3 through V6. 
The ship was docked at the time in a major port so, after 
initial stabilisation, the patient was transferred directly for 
emergency percutaneous coronary intervention rather than 
undergoing fibrinolysis on board. Cardiac enzymes levels were 
repeated prior to his transfer and all remained within normal 
limits, corresponding to approximately 20 h from his initial 
chest pain and 13 h from the time of first presentation. In 
hospital, angiography subsequently showed a 99% occlusion 
of the right coronary artery, which was successfully stented.
DISCUSSION
All modern cruise ships are required to have the capa-
bility of performing ECGs and measuring cardiac enzymes 
[1]. Admission to rule out MI is a common event on cruise 
ships with an elderly cruising population and an increasingly 
mature workforce.
When first assessed, the patient described was thought 
unlikely to be experiencing cardiac chest pain, based on the 
nature of his symptoms and an assessment of pre-existing 
risk factors. Each episode of pain lasted only a minute or 
two and the association with caffeine and nicotine intake 
suggested spasmodic oesophagitis as a more likely diagno-
sis. Accordingly he was treated with antacids and anxiolytics. 
Anti-platelet and anticoagulation therapies were not insti-
gated because the likelihood of acute coronary syndrome 
(ACS) was felt to be very low.
Within the appropriate clinical setting, elevated levels 
of troponin can indicate a diagnosis of non-ST elevation MI 
as well as confirm ST elevation MI, but unstable angina, the 
third subset of ACS patients, remains a distinct possibility 
when cardiac enzymes do not rise above the normal range 
in patients with chest pain.
In retrospect it is apparent that this patient was ex-
periencing unstable angina at initial presentation, albeit 
with a very short history of atypical symptoms, and that 
this was followed by MI within 24 h of symptom onset. 
The absence of elevated cardiac enzymes when the pa-
tient returned, 13 h after the initial presentation and 5 h 
after discharge, suggests that infarction occurred after the 
period of in-patient monitoring and observation.
The reported probability of secondary events occurring 
subsequent to an episode of ACS without elevated troponins 
varies greatly; 30-day mortality rates from 0.3% to 4.5% 
[2, 3] have been described. Rates of subsequent MI in 
unstable angina patients have been recorded at 2.3% to 
4.3% in a 43 day follow up period [4] and an incidence of 
5.4% was found for the combined end-point of death or MI 
in unstable angina 11 weeks after an episode of ACS [5]. 
The patient in this case report experienced a subsequent 
cardiac event just 13 h after his initial presentation to the 
ship’s medical services and approximately 20 h after his 
first ever symptom. It is fortunate that he was still under 
active review and the ship was in port.
This case raises concerns over how best to manage 
the not infrequent scenario of a chest pain patient with no 
Figure 1. Electrocardiograms of the inferior leads taken at initial presentation (A) and when the patient returned with severe chest pain 
13 h later (B). The second trace shows the development of ST segment elevation in leads III and aVF
A. At initial presentation: 7 p.m. 
B. At second visit: 8 a.m.
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elevation of troponins in the maritime environment. These 
patients are at significant risk of death or infarction within 
the next 30 days if the diagnosis is unstable angina, but 
they will not get a full work-up to establish diagnosis prior to 
discharge from the ship’s medical centre because no cruise 
ship has the capability for stress-testing or further imaging 
on board. It is also quite possible that these patients will 
not get stress-tested within 72 h of discharge either, as 
recommended [6]. The limitations of current investigational 
capabilities on board ships leave both the maritime physi-
cian and his patient in an unenviable position.
CONCLUSIONS
Over-reliance on shipboard troponin testing as a means 
of clearing a patient with ACS for discharge is a potentially 
hazardous strategy in that it fails to recognise patients with 
unstable angina. There is significant risk to morbidity and 
mortality in these patients if they are not diagnosed and 
treated. Ultimately, no matter how carefully one reviews, 
the correct diagnosis may still be missed in some of these 
cases.
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